In the 2021 WHO classification of CNS tumors, the medulloblastoma types are designated as WNT-activated, SHH-activated/TP53-wildtype, SHH-activated/TP53-mutant and non-WNT/non-SHH (Group 3/4) [7]. Here, TP53 is linked to central nervous system neoplasm.